Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Februar 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.6k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • BulderB Offline
    BulderB Offline
    Bulder
    wrote on sidst redigeret af
    #927

    Den står 2-2. Novod og Barclays ned. MS og DDB op.

    1 Reply Last reply
    0
    • D Offline
      D Offline
      deleted-user
      wrote on sidst redigeret af
      #928

      Børen - "Gen­mab-kurs­mål sæn­kes på stri­be", det må således være den halve sandhed hvis den står 2-2

      1 Reply Last reply
      0
      • SolsenS Offline
        SolsenS Offline
        Solsen
        wrote on sidst redigeret af
        #929

        Fint at GS. De er ved at bygge en større position op i Genmab.

        1 Reply Last reply
        0
        • SolsenS Offline
          SolsenS Offline
          Solsen
          wrote on sidst redigeret af
          #930

          GS har så vidt jeg kan se +3% af Genmab aktier.

          1 Reply Last reply
          0
          • JørgenVarnæsJ Offline
            JørgenVarnæsJ Offline
            JørgenVarnæs
            wrote on sidst redigeret af
            #931

            GS har ikke ligefrem for vane at have et target, der ligger nord for den aktuelle kurs. Det er måske den reelle grund til deres revision...

            1 Reply Last reply
            0
            • JørgenVarnæsJ Offline
              JørgenVarnæsJ Offline
              JørgenVarnæs
              wrote on sidst redigeret af
              #932

              Omkring timing af GEN1046, så er det nærmeste vi kom i går vist JvdW svar til Verdult - https://www.fool.com/earnings/call-transcripts/2021/02/23/genmab-as-gmab-q4-2020-earnings-call-transcript/

              1 Reply Last reply
              0
              • JørgenVarnæsJ Offline
                JørgenVarnæsJ Offline
                JørgenVarnæs
                wrote on sidst redigeret af
                #933

                Her siger han, at man forventer data fra expansion cohorts, men ikke meget andet

                1 Reply Last reply
                0
                • Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktør
                  wrote on sidst redigeret af
                  #934

                  Jyske Banks anbefaling: https://www.proinvestor.com/investornyt/672464/genmab-jyske-bank-anbefaling-haeves-til-kob-fra-hold

                  1 Reply Last reply
                  0
                  • C Offline
                    C Offline
                    Connecting
                    wrote on sidst redigeret af
                    #935

                    Sydbank analyser post regnskab:

                    1 Reply Last reply
                    0
                    • C Offline
                      C Offline
                      Connecting
                      wrote on sidst redigeret af
                      #936

                      https://markets.sydbank.dk/PublicationsWebHandler/Default.aspx?ID=0042061-076403

                      1 Reply Last reply
                      0
                      • JørgenVarnæsJ Offline
                        JørgenVarnæsJ Offline
                        JørgenVarnæs
                        wrote on sidst redigeret af
                        #937

                        Det ser ud til, at 2021 bliver anderledes - nu kan vi se frem til masser af read-outs og ikke kun sidde og kigge på recepttal for dara. Det bliver lidt mere som de gode gamle dage

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #938

                          yes, Genmab was always blamed to be a 'one trick pony'. So now that that is changing, we suddenly invest too much...

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #939

                            I mean, we knew the products in the pipeline, so we knew how much investment will have to go into that. So for me, higher investmenst now means bringing investments forward. So my only conclusion can be that the majority of the analysts think that Genmab is going to fast I guess?

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #940

                              It
                              is why I asked
                              @troldmanden yesterday, ‘if they would delay that 1bn for a year, so that cost would be in line with analysts expectations, would you feel better?’ Personally, I don’t understand that…

                              1 Reply Last reply
                              0
                              • JørgenVarnæsJ Offline
                                JørgenVarnæsJ Offline
                                JørgenVarnæs
                                wrote on sidst redigeret af
                                #941

                                This is one of those delightful moments, where we can put our money where out mouths are - Through the collaborations GEN has mitigated the risks of not being able to handle scale and speed in these large programs - now GEN must put up the money to make these things happen. That will hopefully be worth the investment

                                1 Reply Last reply
                                0
                                • JørgenVarnæsJ Offline
                                  JørgenVarnæsJ Offline
                                  JørgenVarnæs
                                  wrote on sidst redigeret af
                                  #942

                                  If analysts just see elevated costs - fine by me

                                  1 Reply Last reply
                                  0
                                  • JørgenVarnæsJ Offline
                                    JørgenVarnæsJ Offline
                                    JørgenVarnæs
                                    wrote on sidst redigeret af
                                    #943

                                    Did anybody else notice the “Significant CMC investment” for both epco and GEN1046 on slide no 13 yesterday?

                                    1 Reply Last reply
                                    0
                                    • JørgenVarnæsJ Offline
                                      JørgenVarnæsJ Offline
                                      JørgenVarnæs
                                      wrote on sidst redigeret af
                                      #944

                                      In other words - we are “buying” a factory

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #945

                                        can we call it research lab please...

                                        1 Reply Last reply
                                        0
                                        • JørgenVarnæsJ Offline
                                          JørgenVarnæsJ Offline
                                          JørgenVarnæs
                                          wrote on sidst redigeret af
                                          #946

                                          Well, there is finally need for substantial production of molecules to feed the clinical programs

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger